Setyo Nugroho GM, Marhana IA, Kusumastuti EH, Semedi BP, Maimunah U, Lefi A, Suyanto E, Rosyid AN, Wahyu D, Wiratama PA, Anggoro A, Rusgi Yandi IK, Djuanda SN, Lilihata JG, Supriadi, Pratama Rinjani LG, Nugraha RA. Interleukin-6 (IL-6) expression of lung tissue in COVID-19 patient severity through core biopsy post mortem.
Ann Med Surg (Lond) 2022;
82:104648. [PMID:
36157132 PMCID:
PMC9481471 DOI:
10.1016/j.amsu.2022.104648]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 09/06/2022] [Accepted: 09/10/2022] [Indexed: 12/15/2022] Open
Abstract
Introduction
In COVID-19 patients, Interleukin-6 (IL-6) will increase, and the production of antigens will be excessive, which will cause excessive inflammation of the tissues, especially the respiratory tract, which causes fibrosis in the lungs and can lead to death.
Objective
To analyze IL-6 expression of lung tissue in COVID-19 patient severity.
Methods
The study is an observational analytic design from July to December 2020. COVID-19 patient severity who died was examined for IL-6 expression on lung tissue. The lung tissue sampling uses the core biopsy method.
Results
The total number of samples obtained was 38 samples. Characteristics of patients with a mean age of patients were 48 years, male, the most common chief complaint was shortness of breath, mean symptom onset was 5 days, patient length of stay was 10 days, the most common cause of death was a combination of septic shock and ARDS and the most common comorbid diabetes mellitus. There is an increased WBC, neutrophils, platelets, procalcitonin, CRP, BUN, creatinine serum, AST, ALT, and D-dimer. In this study, the average tissue IL-6 expression was 72.63, with the highest frequency of strong positive 47.4%.
Conclusion
An increase in IL-6 expression on lung tissue showed the severity of COVID-19 infection.
IL-6 levels increased in severity of COVID-19.
IL-6 is elevated in comorbid COVID-19 patients.
IL-6 increases inflammatory indicators in COVID-19.
Collapse